Influenza A H1N1 M2 Antibody (14C2) - (A/WSN/1933) | Novus Biologicals NB100-2073 product information

product summary

company name :

Novus Biologicals

other brands :

IMGENEX

product type :

antibody

product name :

Influenza A H1N1 M2 Antibody (14C2) - (A/WSN/1933)

catalog :

NB100-2073

quantity :

100 ug (also 0.025 mg)

price :

409 USD

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

14C2

application :

western blot, immunocytochemistry, neutralization, immunoprecipitation, flow cytometry

more info or order :

Novus Biologicals product webpage

citations: 8

Reference
Tsai M, Osman W, Adair J, ElMergawy R, Chafin L, Johns F, et al. The E3 ligase subunit FBXO45 binds the interferon-λ receptor and promotes its degradation during influenza virus infection. J Biol Chem. 2022;298:102698 pubmed publisher
Schmid E, Pang I, Carrera Silva E, Bosurgi L, Miner J, Diamond M, et al. AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity. elife. 2016;5: pubmed publisher
Londino J, Lazrak A, Noah J, Aggarwal S, Bali V, Woodworth B, et al. Influenza virus M2 targets cystic fibrosis transmembrane conductance regulator for lysosomal degradation during viral infection. FASEB J. 2015;29:2712-25 pubmed publisher
Pang I, Pillai P, Iwasaki A. Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I. Proc Natl Acad Sci U S A. 2013;110:13910-5 pubmed publisher
Londino J, Lazrak A, Jurkuvenaite A, Collawn J, Noah J, Matalon S. Influenza matrix protein 2 alters CFTR expression and function through its ion channel activity. Am J Physiol Lung Cell Mol Physiol. 2013;304:L582-92 pubmed publisher
Lin S, Lin Y, Chong P, Wu S. Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles. PLoS ONE. 2012;7:e39075 pubmed publisher
Wei H, Chang W, Lin S, Liu W, Chang D, Chong P, et al. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines. Vaccine. 2011;29:7163-72 pubmed publisher
Pan Y, Wei H, Chang C, Lin C, Wei T, Wu S, et al. Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation. J Biomed Biotechnol. 2010;2010:506363 pubmed publisher

product information

brand :

Novus Biologicals, a Bio-Techne brand

catalog number base :

NB100-2073

SKU :

NB100-2073

product name :

Influenza A H1N1 M2 Antibody (14C2) - (A/WSN/1933)

description :

The Influenza A H1N1 M2 Antibody (14C2) - (A/WSN/1933) from Novus Biologicals is a mouse monoclonal antibody to Influenza A H1N1 M2. This antibody reacts with human,influenza a virus h1n1,virus,frog - xenopus (african clawed frog). The Influenza A H1N1 M2 Antibody (14C2) - (A/WSN/1933) has been validated for the following applications: Immunoprecipitation,Block/Neutralize,Immunocytochemistry/ Immunofluorescence,Flow Cytometry,Western Blot.

target :

Influenza A H1N1 M2

unit size :

100 ug (also 0.025 mg)

category :

Primary Antibodies

buffer :

PBS with 1 mg/ml BSA

clonality :

Monoclonal

clone :

14C2

concentration :

1 mg/ml

conjugate :

Unconjugated

host :

Mouse

immunogen :

M2 protein from A/WSN/33-infected CV1 cell lysate.

isotype :

IgG1 Kappa

purity :

Protein A purified

species :

Human,Influenza A Virus H1N1,Virus,Xenopus

specificity :

Influenza A H1N1 M2 (A/WSN/1933)

storage :

Store at -20C. Avoid freeze-thaw cycles.

applications :

Immunoprecipitation,Block/Neutralize,Immunocytochemistry/ Immunofluorescence,Flow Cytometry,Western Blot

USD :

399

USD 2025 :

409 USD

alt names :

Influenza M2

more info or order :

Novus Biologicals product webpage